This week saw major developments in healthcare AI, focusing on agentic AI systems that improve medical decision-making.

Stanford Health AI Week brought together thousands of experts to discuss integrating AI into clinics. A key theme was overcoming challenges like fragmented medical data and creating better evaluation methods for AI tools.

The FDA launched Elsa, an AI agent that summarizes adverse drug events and accelerates clinical reviews. Meanwhile, a global KPMG survey found 85% of health systems now develop their own AI solutions, with agentic AI ranking as a top priority.

New innovations emerged too: Diagnostics.ai unveiled a transparent AI platform for PCR testing, while Dutch startup ReportAid secured €2.2M to fix Europe's fragmented healthcare data using AI.

Policy efforts advanced through the AI Spring Summit where leaders planned certification programs for medical AI tools. Experts emphasized balancing innovation with patient safety as generative AI becomes common in diagnosis and treatment plans.